David A. Siegel Insmed Inc Transaction History
Two Sigma Advisers, LP
- $46.1 Billion
- Q2 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Insmed Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 17,500 shares of INSM stock, worth $2.82 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,500
Previous 157,200
88.87%
Holding current value
$2.82 Million
Previous $12 Million
85.32%
% of portfolio
0.0%
Previous 0.03%
Shares
32 transactions
Others Institutions Holding INSM
# of Institutions
582Shares Held
203MCall Options Held
2.84MPut Options Held
3.26M-
Darwin Global Management, Ltd. St. Helier, Y919.3MShares$3.12 Billion82.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$2.85 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$2.3 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$1.81 Billion0.13% of portfolio
-
Baker Bros. Advisors LP New York, NY7.71MShares$1.24 Billion7.87% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $21.9B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...